FOLD, XLB, IYT, CZZ, PDN, EXPR Are Seasonally Ripe To Go Up In the Next Five Weeks
December 19, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of Amicus Therapeutics Inc. (NASDAQ:FOLD), Materials Select Sector SPDR (NYSE:XLB), iShares Dow Jones Transportation Average Index Fund (NYSE:IYT), Cosan Limited (NYSE:CZZ), PowerShares FTSE RAFI Developed Markets ex-U.S. Small-Mid Portfolio (NYSE:PDN), Express Inc. (NYSE:EXPR) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
The following stocks are expected to go Up:
Symbol Company Expected Return Odds By The Following Date FOLD Amicus Therapeutics Inc. 9.35% 100.00% (9 of 9) Thursday, December 29th 2016 XLB Materials Select Sector SPDR 3.01% 88.24% (15 of 17) Thursday, December 29th 2016 IYT iShares Dow Jones Transportation Average Index Fund 1.72% 84.62% (11 of 13) Tuesday, December 27th 2016 CZZ Cosan Limited 9.00% 88.89% (8 of 9) Tuesday, December 27th 2016 PDN PowerShares FTSE RAFI Developed Markets ex-U.S. Small-Mid Portfolio 2.43% 88.89% (8 of 9) Wednesday, December 28th 2016 EXPR Express Inc. 2.73% 100.00% (6 of 6) Tuesday, December 27th 2016Amicus Therapeutics Inc. (NASDAQ:FOLD) - Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its principal product is the migalastat HCl, a small molecule, which has completed Phase III studies that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease. The company is also developing SD-101, which is in Phase III clinical study for the treatment of the genetic connective tissue disorder epidermolysis bullosa; ATB200 that is in Phase II studies to treat pompe disease; AT2221, which is in Phase II studies for the treatment of pompe disease; and AT3375 to treat Parkinson's disease. The company has strategic alliance with GlaxoSmithKline plc to develop and commercialize migalastat as a monotherapy and in combination with ERT for Fabry disease. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey..
Materials Select Sector SPDR (NYSE:XLB) - MATERIALS SS SPDR.
iShares Dow Jones Transportation Average Index Fund (NYSE:IYT) - ISHARES DJ TRANS.
Cosan Limited (NYSE:CZZ) - Cosan Limited, together with its subsidiaries, engages in piped natural gas, Logistics service, agricultural land, lubricant, sugar and ethanol, and fuel businesses primarily in Brazil and internationally. The company s Ra zen Energia segment produces and markets various products derived from sugar cane, including raw sugar, and anhydrous and hydrated ethanol. This segment is also involved in activities related to energy cogeneration from sugarcane bagasse; and holds interests in companies involved in research and development on new technology. Its Ra zen Combust veis segment distributes and markets fuels, primarily through a franchised network of service stations under the Shell brands in Brazil. The company s COMG S segment distributes piped natural gas to customers in the industrial, residential, commercial, automotive, thermogeneration, and cogeneration sectors in part of the State of Sao Paulo. Its Cosan Log stica segment provides logistics services for transport, storage, and port loading of commodities, primarily for sugar products; and leasing or lending of locomotives, wagons, and other railway equipment. The company s Radar segment is involved in buying, managing, selling, and leasing agricultural land. Its Lubricants segment produces and distributes lubricants under the Mobil and Comma names. The company operates a network of approximately 5,682 Shell service stations and 950 convenience stores, as well as 63 distribution terminals and 59 airports terminals. Cosan Limited was incorporated in 2007 and is based in S o Paulo, Brazil..
PowerShares FTSE RAFI Developed Markets ex-U.S. Small-Mid Portfolio (NYSE:PDN) - PowerShares FTSE RAFI Developed Markets exU.S. SmallMid Portfolio.
Express Inc. (NYSE:EXPR) - Express, Inc. operates as a specialty apparel and accessories retailer. It offers apparel and accessories for women and men between 20 and 30 years across various aspects of lifestyles, including work, casual, jeanswear, and going-out occasions. The company sells its products through its e-commerce Website, express.com; mobile app; and franchisees Express locations in Latin America, the Middle East, and South Africa. As of January 30, 2016, it operated 653 stores in the United States, Canada, and Puerto Rico. The company was formerly known as Express Parent LLC and changed its name to Express, Inc. in May 2010. Express, Inc. was founded in 1980 and is based in Columbus, Ohio..
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net